UK markets close in 4 hours 12 minutes

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
129.36+1.05 (+0.82%)
At close: 04:00PM EDT
129.21 -0.15 (-0.12%)
After hours: 06:27PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts17171917
Avg. Estimate-1.61-1.62-6.45-2.93
Low estimate-2.1-2.27-9.13-8.04
High estimate-1.09-1.11-3.221.12
Year ago EPS-1.61-1.72-7.2-6.45
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts15152020
Avg. Estimate256.98M285.81M1.09B1.65B
Low estimate240.4M260.3M1.01B1.3B
High estimate275.67M311.2M1.15B2.28B
Year ago sales192.8M218.69M844.29M1.09B
Sales growth (year/est)33.30%30.70%29.60%50.80%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-1.61-1.57-1.54-1.84
Actual EPS-1.61-1.72-2.16-2
Difference0-0.15-0.62-0.16
Surprise %0.00%-9.60%-40.30%-8.70%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-1.61-1.62-6.45-2.93
7 days ago-1.6-1.6-6.4-2.94
30 days ago-1.69-1.56-6.27-3.13
60 days ago-1.62-1.48-6.2-3.2
90 days ago-1.69-1.53-6.32-2.86
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/A1
Up last 30 days9579
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.5.80%N/AN/AN/A
Current year10.40%N/AN/AN/A
Next year54.60%N/AN/AN/A
Next 5 years (per annum)7.86%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A